FDA Cites Chinese Firm for GMP Noncompliance
This article was originally published in PharmAsia News
Executive Summary
FDA has cited a Chinese firm, Kunshan Chemical and Pharmaceutical Company located in Kunshan City. Jiangsu Province, in a Sept. 6 warning letter for "significant deviations" in GMPs related to the manufacture of active pharmaceutical ingredients (APIs)